Call Pharmacy +91 90310 13315
H

Telmijub Beta 25 Tablet

Telmisartan (40mg) + Metoprolol (25mg)

₹100.00 ₹101.972% Off


Product Code: 32530
Availability: In Stock
Manufacturer: Jubilant Life Sciences
Constituents

Telmisartan (40mg) + Metoprolol (25mg)

Usage of Telmijub Beta 25 Tablet

Telmijub Beta 25 Tablet is used in the treatment of high blood pressure.

Possible Side-effects

Common
  • Headache
  • Weakness
  • Dizziness
  • Cold extremities
  • Slow heart rate
  • Increased potassium level in blood
  • Numbness of extremity
  • Decreased blood pressure

Unit

10 tablet er in 1 strip

Manufacturer

Jubilant Life Sciences

Disclaimer

Image shown is a representation and may slightly vary from the actual product. Every effort is made to maintain accuracy of all information displayed.

How to use Telmijub Beta 25 Tablet

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Telmijub Beta 25 Tablet is to be taken with food.

How Medicine Works

Telmijub Beta 25 Tablet is a combination of two blood-pressure lowering medicines: Telmisartan and Metoprolol Succinate. Telmisartan is an angiotensin receptor blocker (ARB). It works by blocking the chemical angiotensin, thereby relaxing blood vessels. Metoprolol Succinate is a beta blocker which works specifically on the heart to reduce heart rate and lower blood pressure. Together they allow the blood to flow more smoothly and the heart to pump more efficiently.

Related Warnings

Taking Metoprolol with alcohol may have additive effects in lowering your blood pressure. You may experience headache, dizziness, lightheadedness, fainting, and/or changes in pulse or heart rate.

Telmijub Beta 25 Tablet is unsafe to use during pregnancy.
There is positive evidence of human fetal risk, but the benefits from use in pregnant women may be acceptable despite the risk, for example in life-threatening situations. Please consult your doctor.

Telmijub Beta 25 Tablet is probably safe to use during lactation. Limited human data suggests that the drug does not represent a significant risk to the baby.

Telmijub Beta 25 Tablet may make you feel dizzy, sleepy, tired, or decrease alertness. If this happens, do not drive.

Telmijub Beta 25 Tablet is safe to use in patients with kidney disease. No dose adjustment of Telmijub Beta 25 Tablet is recommended.

Telmijub Beta 25 Tablet should be used with caution in patients with liver disease. Dose adjustment of Telmijub Beta 25 Tablet may be needed. Please consult your doctor.

Expert Advice

Frequently Asked Questions (FAQs)

Similar Products

In-Stock
Teleact Beta Tablet

Teleact Beta Tablet

₹11093.00
In-Stock
Temcar-Beta Tablet

Temcar-Beta Tablet

₹140119.00
In-Stock
Cortel M 25 Tablet

Cortel M 25 Tablet

₹8382.00
In-Stock
Embeta Tm 25mg Tablet

Embeta Tm 25mg Tablet

₹179175.00
In-Stock
Metfirst-T 25 Tablet

Metfirst-T 25 Tablet

₹10085.00

Featured Products

In-Stock
A-Z Tablet

A-Z Tablet

₹110107.80
Out of Stock
Gastid Syrup

Gastid Syrup

₹7775.46
In-Stock
Calcit SG Capsule

Calcit SG Capsule

₹124121.13